Neanderthal gene variant increases muscle mass
Analysis based on 20 articles · First reported Aug 05, 2026 · Last updated Sep 04, 2026
The study is primarily of scientific interest and is unlikely to directly impact financial markets. It may influence the biotechnology and genetics research sectors by highlighting potential targets for muscle-related therapies, but any commercial applications are speculative and far off.
A study published in Current Biology on August 5, 2026, led by Hugo Zeberg of Karolinska Institute and Philipp Kanis of Max Planck Institute for Evolutionary Anthropology, found that a Neanderthal-derived variant of the growth hormone receptor gene increases muscle mass in modern humans. The variant, inherited through interbreeding about 47,000 years ago, causes cells to respond more strongly to growth hormone. Laboratory experiments showed cells with the Neanderthal receptor grew about 40% more than those with the common modern version. Analysis of over 1.1 million adults found carriers have on average 270-285 grams more muscle mass and slightly greater height. The effect appears after puberty, as no difference was seen in children under 11. The variant is rare in Europe (0.5%) but common in South and East Asia, reaching up to 24% in Pakistan. Carriers also show subtle Neanderthal-like facial features such as shorter tooth roots and jaw differences. The study highlights how ancient interbreeding continues to influence human biology.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard